We recently reported that in spite of their failure to express the tumor suppressor and clock gene Per2, our tissue-isolated human breast cancer xenografts exhibit daily oscillations in the expression of Clock, Cry1 and Bmal1 that were disrupted in the absence of a circadian melatonin signal [32]. This evidence concerns the gene BMAL1 and breast cancer.